HEI Therapeutics
ShutdownWebsite unreachable since Oct 21, 2026
HEI Therapeutics develops ThyroidSense, the world's first medical-grade home-monitoring device for chronic hypothyroidism patients. The system enables real-time TSH tracking from home with remote care capabilities, addressing a condition affecting over 250 million people globally and helping reduce the $50B annual societal cost of poorly regulated patients in the US.
- Healthcare Technology
- Medical Devices
- Digital Health
- Internet of Things
- Hardware
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Chronic hypothyroidism affects more than 250 million people globally, yet patients must make frequent hospital visits for blood tests to monitor their condition and regulate medication. Poor regulation of medication increases patient risks for developing comorbidities such as diabetes by 15% from just six months of poor control, and 33% of patients experience poor regulation severe enough to increase sickness and comorbidity risk today.
Solution
HEI Therapeutics provides ThyroidSense, a medical-grade home-monitoring device that enables hypothyroidism patients to track their condition in real-time from home and receive remote care. The solution allows patients to measure TSH levels outside clinical settings while clinicians can access results digitally, supporting better medication regulation and reducing hospital visit frequency. The platform empowers patients to adjust and optimize medication from home under medical guidance, addressing the significant gap between clinic-based monitoring and daily patient needs.
Target Audience
Primary users are the 250 million chronic hypothyroidism patients worldwide who need frequent TSH monitoring, along with endocrinologists and thyroid care providers seeking remote patient management tools.
Features
- Medical-grade home-monitoring device for TSH measurement with clinically validated accuracy
- Real-time condition tracking from home, eliminating frequent hospital blood-test visits
- Remote care integration enabling clinicians to monitor patient data and adjust treatment plans without in-person visits
- Patient-empowerment design supporting self-management of medication plans alongside symptom monitoring
- Digital assistant capabilities to help patients adhere to medication plans, diet, and exercise regimens